Piramal Pharma Reports Sustainability Progress in FY2024-25 with Energy-Efficient Tech, Renewable Energy, and Community Development Programs

Piramal Pharma Limited (PPL) has released its annual Sustainability Report for the financial year 2024-25, highlighting its progress in Environment, Social, and Governance pillars. The report focuses on measurable advancements, new initiatives, and a deepened commitment to sustainability objectives. Directed efforts include transitioning to energy-efficient technologies, renewable energy adoption, embracing circularity through waste segregation and water conservation, and community development programs focused on education and skill building. The report is prepared in accordance with the Global Reporting Initiative (GRI) Universal Standards 2021 and aligned with the United Nations Sustainable Development Goals (UN SDGs). The scope and boundary of the report cover three business units - Piramal Pharma Solutions, Piramal Critical Care, and Piramal Consumer Healthcare - having development and manufacturing facilities across India, the United Kingdom, and North America.